Glutathione reductase underlies the stability of mutant p53 by antagonizing protein glutathionylation
Mutp53 level is widely variable among individual cancer cells in tumor tissues, and within cells a higher level of mutp53 is usually observed in the nucleus as compared to the cytoplasm. This spatial heterogeneity in mutp53 expression has been well documented and likely plays an important role in tu...
Saved in:
| Main Authors: | Liansheng Wang, Suqin Zhong, Xinru Fan, Yuxue Xu, Meimei Wang, Youcui Xu, Yuanyuan Cai, Zhong Cao, Zhiming Ye, Longping Wen, Pengfei Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Redox Biology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725000357 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers
by: Na Zhang, et al.
Published: (2025-05-01) -
p53 in colorectal cancer: from a master player to a privileged therapy target
by: Sicheng Yan, et al.
Published: (2025-06-01) -
Lipidome atlas of p53 mutant variants in pancreatic cancer
by: Kian Cotton, et al.
Published: (2025-04-01) -
Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic tools
by: Diana Spiegelberg, et al.
Published: (2025-01-01) -
A Narrative Review of the Role of S-Glutathionylation in Bacteria
by: Luca Federici, et al.
Published: (2025-02-01)